Avanos Medical (AVNS) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.02% |
| Dec 31, 2025 | 32.00% |
| Sep 30, 2025 | 41.56% |
| Jun 30, 2025 | 6.25% |
| Mar 31, 2025 | 30.10% |
| Dec 31, 2024 | 51.33% |
| Sep 30, 2024 | 23.25% |
| Jun 30, 2024 | 19.13% |
| Mar 31, 2024 | 19.41% |
| Dec 31, 2023 | 17.83% |
| Sep 30, 2023 | 18.34% |
| Jun 30, 2023 | 42.80% |
| Mar 31, 2023 | -21.49% |
| Dec 31, 2022 | -13.30% |
| Sep 30, 2022 | 19.70% |
| Jun 30, 2022 | 11.48% |
| Mar 31, 2022 | -16.21% |
| Dec 31, 2021 | 0.65% |
| Sep 30, 2021 | -15.34% |
| Jun 30, 2021 | -26.86% |
| Mar 31, 2021 | -17.72% |
| Dec 31, 2020 | -30.99% |
| Sep 30, 2020 | -44.65% |
| Jun 30, 2020 | -31.06% |
| Mar 31, 2020 | -23.87% |
| Dec 31, 2019 | -16.42% |
| Sep 30, 2019 | -21.91% |
| Jun 30, 2019 | -28.16% |
| Mar 31, 2019 | -31.73% |
| Dec 31, 2018 | -17.28% |